US20010007904A1 - Process for manufacture of in vivo stain composition - Google Patents
Process for manufacture of in vivo stain composition Download PDFInfo
- Publication number
- US20010007904A1 US20010007904A1 US09/759,808 US75980801A US2001007904A1 US 20010007904 A1 US20010007904 A1 US 20010007904A1 US 75980801 A US75980801 A US 75980801A US 2001007904 A1 US2001007904 A1 US 2001007904A1
- Authority
- US
- United States
- Prior art keywords
- reaction mixture
- tbo
- solution
- minutes
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 41
- 230000008569 process Effects 0.000 title claims abstract description 31
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 18
- 239000000203 mixture Substances 0.000 title description 22
- 238000001727 in vivo Methods 0.000 title description 3
- 239000011541 reaction mixture Substances 0.000 claims abstract description 69
- 239000002253 acid Substances 0.000 claims abstract description 16
- 230000001590 oxidative effect Effects 0.000 claims abstract description 12
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 claims abstract description 12
- -1 thiosulfate ions Chemical class 0.000 claims abstract description 9
- 230000002194 synthesizing effect Effects 0.000 claims abstract 2
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 claims description 14
- QZHXKQKKEBXYRG-UHFFFAOYSA-N 4-n-(4-aminophenyl)benzene-1,4-diamine Chemical group C1=CC(N)=CC=C1NC1=CC=C(N)C=C1 QZHXKQKKEBXYRG-UHFFFAOYSA-N 0.000 claims description 13
- WHLSUYBVBOSJOQ-UHFFFAOYSA-N 2-hydroxysulfonothioyl-4-n,4-n-dimethylbenzene-1,4-diamine Chemical compound CN(C)C1=CC=C(N)C(S(O)(=O)=S)=C1 WHLSUYBVBOSJOQ-UHFFFAOYSA-N 0.000 claims description 12
- 239000007795 chemical reaction product Substances 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 18
- 238000003786 synthesis reaction Methods 0.000 abstract description 12
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 52
- 239000000523 sample Substances 0.000 description 33
- 238000003756 stirring Methods 0.000 description 33
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 33
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 32
- 239000000047 product Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000011592 zinc chloride Substances 0.000 description 19
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 18
- 238000000746 purification Methods 0.000 description 16
- 239000011780 sodium chloride Substances 0.000 description 16
- 235000005074 zinc chloride Nutrition 0.000 description 14
- 239000012065 filter cake Substances 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 239000008213 purified water Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 6
- 229920001903 high density polyethylene Polymers 0.000 description 6
- 239000004700 high-density polyethylene Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000008139 complexing agent Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000536 complexating effect Effects 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000002920 hazardous waste Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- SPJXGIDHWJCRSL-UHFFFAOYSA-N 2-[[4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound CSCCC(C(O)=O)NC(=O)C(CC(C)C)NC(=O)OC(C)(C)C SPJXGIDHWJCRSL-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- TYYRFZAVEXQXSN-UHFFFAOYSA-H aluminium sulfate hexadecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O TYYRFZAVEXQXSN-UHFFFAOYSA-H 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 231100000647 material safety data sheet Toxicity 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000001226 reprecipitation Methods 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 239000005336 safety glass Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- MDAXKAUIABOHTD-UHFFFAOYSA-N 1,4,8,11-tetraazacyclotetradecane Chemical compound C1CNCCNCCCNCCNC1 MDAXKAUIABOHTD-UHFFFAOYSA-N 0.000 description 1
- 101100072643 Arabidopsis thaliana IPS2 gene Proteins 0.000 description 1
- 101100072645 Arabidopsis thaliana IPS3 gene Proteins 0.000 description 1
- BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 description 1
- 229920002145 PharMed Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000003134 recirculating effect Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B21/00—Thiazine dyes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/36—Control of physical parameters of the fluid carrier in high pressure liquid systems
Definitions
- This invention pertains to improved methods of manufacturing TBO compositions, including the novel compositions which are disclosed in my above-identified prior applications.
- the invention concerns a method and process for manufacturing TBO compositions with improved yield, leading to manufacturing economies and increased productive capacity of the manufacturing equipment.
- FIG. 1 is a process flow diagram, depicting the improved process which I have discovered, for manufacturing TBO products, including the novel TBO product compositions disclosed in my above-identified prior International Application.
- This synthesis is a series of three oxidation steps: (1) oxidation of N,N-dimethyl- ⁇ -phenylenediamine, e.g., with potassium dichromate, to form 2-amino-5-dimethylaminophenyl thiosulfonic acid; (2) condensation of the thiosulfonic acid with o-toluidine, to form the corresponding indamine-thiosulfonic acid; and (3) ring closure of the indamine-thiosulfonic acid, e.g., in the presence of zinc chloride at boiling temperature for about 30 minutes, to form TBO.
- the reaction mixture is then cooled and the TBO product of the ring-closure reaction is complexed and salted out, e.g., by treatment with sodium chloride and zinc chloride, to precipitate the TBO complex, e.g., as an TBO/ZnCl 2 complex.
- Purification may be accomplished by repeated re-solution and re-precipitation, e.g., by re-solution in hot aqueous zinc chloride solution and re-precipitation with sodium chloride/zinc chloride.
- the improvement on this prior art process comprising the step of adding the complexing reagent at a stage earlier than the formation of the third reaction mixture, preferably before the formation of the second reaction mixture.
- the conversion of the starting material, N,N′-dimethy- ⁇ -phenylene-diamine, to form a first intermediate, 2-amino-5-dimethylaminophenyl thiosulfonic acid was preferably carried out at a temperature of below about 10° C., and most preferably at about 5° C., for approximately 20 minutes, then warming the reaction mixture to approximately 20-25° C., then adding the thiosulfonization agent (a source of thiosulfate ions, e.g., sodium thiosulfate pentahydrate), then raising the temperature of the reaction mixture to an elevated temperature above room temperature, preferably to about 60° C. and continuing to stir the reaction mixture for approximately 30 minutes.
- the thiosulfonization agent a source of thiosulfate ions, e.g., sodium thiosulfate pentahydrate
- the improvement of the present invention for increasing the yield of TBO-complex product from the process of the present application, comprises the steps of introducing a source of thiosulfonate ions into the first reaction mixture to form the first intermediate, while maintaining the reaction mixture at a reduced temperature of about 10° C. and continuing the reaction at this reduced temperature before raising the temperature to an elevated temperature.
- indamine thiosulfonic acid comprises the steps of oxidizing N,N′-dimethyl- ⁇ -phenylene diamine in a reaction mixture containing it and an oxidizing agent in a reaction mixture and introducing a source of thiosulfate ions into the reaction mixture, maintaining the temperature of the oxidation-thiosulfonization reaction mixture at or below about 10° C. for approximately 30 minutes, and raising the temperature to an elevated temperature for approximately 30 minutes, to form a solution of indamine thiosulfonic acid dissolved in the reaction mixture.
- the thiosulfonization agent is introduced into the first oxidation reaction mixture at a reduced temperature of from about 5-10° C. and the reaction is continued at that reduced temperature before warming the reaction mixture to an elevated temperature of about 60° C., rather than warming the first reaction mixture to approximately 20-25°C. before introducing the thiosulfonization agent and then warming the resulting oxidization-thiosulfonization reaction mixture to the elevated temperature.
- the manufacturing process is continued in accordance the procedures disclosed in my prior International Application, i.e., the intermediate, 2-amino-5-dimethylaminophenyl thiosulfonic acid, is further oxidized and condensed with o-toluidine, in a second reaction mixture, forming a second intermediate, indamine thiosulfonic acid, the second intermediate is further oxidized in a third reaction mixture to close the indamine ring, forming a TBO reaction product, complexing the TBO reaction product in the third reaction mixture, forming a TBO-complex product, and separating the TBO-complex from the third reaction mixture.
- an aqueous solution of the starting material 10 is oxidized 11 , preferably at less than 10° C., especially at about 5°C., by reaction with a suitable oxidizing agent 12 , e.g., potassium dichromate 12 , in the presence of acid, aluminum sulfate and a reagent, 13 (which is believed to complex the intermediate(s) and is used in a later stage of the process to complex the TBO composition components), e.g., zinc chloride.
- a suitable oxidizing agent 12 e.g., potassium dichromate 12
- a reagent, 13 which is believed to complex the intermediate(s) and is used in a later stage of the process to complex the TBO composition components
- zinc chloride e.g., zinc chloride
- a source of thiosulfate ions 14 e.g., sodium thiosulfate
- the reaction is continued at such reduced temperature for approximately 30 minutes and later at an elevated temperature of about 60° C., to form a first reaction mixture 15 containing the first intermediate, 2-amino-5-dimethylaminophenyl thiosulfonic acid.
- the first reaction mixture 15 is then further reacted, preferably at a temperature of not greater than about 10°C., with additional oxidizing agent 16 , e.g., potassium dichromate, and o-toluidine hydrochloride 17 , in a condensation step 18 to form the second intermediate, a condensation product, indamine thiosulfonic acid in the second reaction mixture 19 .
- additional oxidizing agent 16 e.g., potassium dichromate
- o-toluidine hydrochloride 17 e.g., sodium dichromate
- the second reaction mixture 19 is then further oxidized 21 , preferably by addition of a suitable oxidizing agent 22 , e.g., potassium dichromate, at a temperature of not greater than about 10° C. This is followed by the addition of copper sulfate, zinc chloride complexing agent, acid and heating to 100° C. to effect closure of the indamine ring, forming TBO in a third reaction mixture 24 . At this point the TBO is separated from the third reaction mixture and purified.
- a suitable oxidizing agent 22 e.g., potassium dichromate
- the TBO is precipitated from the third reaction mixture by complexation of 24 with a suitable complexing agent 25 , e.g., zinc chloride, to form the complex TBO-zinc chloride double salt.
- a suitable complexing agent 25 e.g., zinc chloride
- the precipitate is filtered 26 from the liquid phase and washed with sodium chloride solution 27 .
- the washed filter cake is then redissolved 28 in a critical 1 volume of water 29 to form a TBO solution 30 , which is then filtered 31 to remove undissolved solids 32 a, which are discarded.
- Zinc Chloride, followed by a critical 2 volume/concentration of sodium chloride 33 is then added to the filtrate 32 to again precipitate the TBO-zinc chloride double salt.
- the TBO-zinc chloride double salt is separated from the mixture by filtration, to yield a TBO-zinc chloride/TBO hydrochloride filter cake 34 .
- the TBO filter cake 34 can be redissolved, filtered, re-precipitated and re-isolated multiple times to achieve the desired degree of purity and yield of TBO.
- the final purified filter cake complex product 34 is then dried 35 , e.g., in conventional convection oven and/or vacuum oven and the dried filter cake 36 is ground and blended 37 to yield the final TBO product 38 .
- the final TBO product contains both the zinc chloride double-salt of TBO (Formula X) and the chloride salt of TBO (Formulas I & II).
- Protective equipment such as gloves, safety glasses, lab coats, and respirators should be worn when handling chemicals according to MSDS guidelines.
- Protective equipment such as gloves, safety glasses, lab coats, and respirators should be worn when handling chemicals according to MSDS guidelines.
- Air Compressor (DF412-2) (9502312538)
- Type K Thermocouple Temperature Recorder (KTx, 6292753, 6355146)
- Packaging Material (containers, lids, labels)
- reaction mixture temperature reaches 100.0° C. ⁇ 3° C. allow the mixture to stir 35 ⁇ 5 minutes.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Biodiversity & Conservation Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Abstract
Description
- This application is a continuation of my co-pending U.S.A. application, Ser. No. 09/110,788, filed Jul. 6, 1998, which was, in turn, a continuation-in-part of International Application, PCT US/97/20981, filed Nov. 13, 1997, entitled IN VIVO STAIN COMPOSITION, PROCESS OF MANUFACTURE, AND METHODS OF USE TO IDENTIFY DYSPLASTIC TISSUE.
- This invention pertains to improved methods of manufacturing TBO compositions, including the novel compositions which are disclosed in my above-identified prior applications.
- In another aspect, the invention concerns a method and process for manufacturing TBO compositions with improved yield, leading to manufacturing economies and increased productive capacity of the manufacturing equipment.
- The various embodiments of the invention and the practice thereof will be apparent to those skilled in the art, from the following detailed description thereof, taken in conjunction with the claims and in conjunction with the drawings, in which:
- FIG. 1 is a process flow diagram, depicting the improved process which I have discovered, for manufacturing TBO products, including the novel TBO product compositions disclosed in my above-identified prior International Application.
- In my prior International Application, I describe a novel general process for manufacturing a TBO product and also a process for manufacturing a TBO composition which has specific chemical characteristics, as required for regulatory approval for in vivo application to human tissue.
- The classic synthesis of TBO, as practiced before the improvements disclosed in my above-identified International Application, is exemplified in the U.S. Pat. No. 418,055, issued Nov. 30, 1989, to Dandliker et al. This synthesis is a series of three oxidation steps: (1) oxidation of N,N-dimethyl-ρ-phenylenediamine, e.g., with potassium dichromate, to form 2-amino-5-dimethylaminophenyl thiosulfonic acid; (2) condensation of the thiosulfonic acid with o-toluidine, to form the corresponding indamine-thiosulfonic acid; and (3) ring closure of the indamine-thiosulfonic acid, e.g., in the presence of zinc chloride at boiling temperature for about 30 minutes, to form TBO. The reaction mixture is then cooled and the TBO product of the ring-closure reaction is complexed and salted out, e.g., by treatment with sodium chloride and zinc chloride, to precipitate the TBO complex, e.g., as an TBO/ZnCl2 complex. Purification may be accomplished by repeated re-solution and re-precipitation, e.g., by re-solution in hot aqueous zinc chloride solution and re-precipitation with sodium chloride/zinc chloride.
- In my above-identified International Application, I disclosed a novel process in which the complexing agent is added to the reaction mixture before the ring closure (third) step of the Dandliker synthesis, preferably before the first oxidation step (
Step 11, of FIG. 1) of the process. The process of my prior International Application was defined as an improvement of the Dandliker process, i.e., in a process which included the steps of - oxidizing N,N-dimethyl-ρ-phenylene diamine ions in a first reaction mixture to form a first intermediate, 2-amino-5-dimethylaminophenyl thiosulfonic acid,
- oxidizing the first intermediate and condensation of the oxidizate with o-toluidine, in a second reaction mixture, to form a second intermediate, indamine thiosulfonic acid,
- oxidizing the second intermediate in a third reaction mixture to close the indamine ring, forming a TBO reaction product, dissolved in the third reaction mixture,
- introducing a complexing reagent into said third reaction mixture, to form a TBO-complex product, and
- separating said TBO-complex from said third reaction mixture,
- the improvement on this prior art process comprising the step of adding the complexing reagent at a stage earlier than the formation of the third reaction mixture, preferably before the formation of the second reaction mixture.
- In the preferred practice of the process disclosed in my prior International Application, the conversion of the starting material, N,N′-dimethy-ρ-phenylene-diamine, to form a first intermediate, 2-amino-5-dimethylaminophenyl thiosulfonic acid, was preferably carried out at a temperature of below about 10° C., and most preferably at about 5° C., for approximately 20 minutes, then warming the reaction mixture to approximately 20-25° C., then adding the thiosulfonization agent (a source of thiosulfate ions, e.g., sodium thiosulfate pentahydrate), then raising the temperature of the reaction mixture to an elevated temperature above room temperature, preferably to about 60° C. and continuing to stir the reaction mixture for approximately 30 minutes.
- I have now discovered that the yield of the TBO product prepared by the overall process disclosed in my prior International Application is significantly increased. The improved-yield process of the present invention is an improvement on the manufacturing process disclosed in my prior International Application, which includes the steps of
- oxidizing N,N′-dimethyl-ρ-phenylene diamine in a first reaction mixture, to form a first intermediate, 2-amino-5-dimethylamino thiosulfonic acid,
- oxidizing the first intermediate and condensing the oxidizate in a second reaction mixture with o-toluidine, forming a second intermediate, indamine thio-sulfonic acid,
- oxidizing the second intermediate to close the indamine ring thereof, forming a TBO-containing reaction product dissolved in a third reaction mixture,
- introducing a complexing agent into a reaction mixture before the formation of the third reaction mixture, to form a TBO-complex product, precipitating the TBO-complex product from the third reaction mixture and separating the TBO-complex product from the precipitate,
- The improvement of the present invention, for increasing the yield of TBO-complex product from the process of the present application, comprises the steps of introducing a source of thiosulfonate ions into the first reaction mixture to form the first intermediate, while maintaining the reaction mixture at a reduced temperature of about 10° C. and continuing the reaction at this reduced temperature before raising the temperature to an elevated temperature.
- I have also discovered an improved process for manufacturing indamine thiosulfonic acid which comprises the steps of oxidizing N,N′-dimethyl-ρ-phenylene diamine in a reaction mixture containing it and an oxidizing agent in a reaction mixture and introducing a source of thiosulfate ions into the reaction mixture, maintaining the temperature of the oxidation-thiosulfonization reaction mixture at or below about 10° C. for approximately 30 minutes, and raising the temperature to an elevated temperature for approximately 30 minutes, to form a solution of indamine thiosulfonic acid dissolved in the reaction mixture.
- In the improved-yield process of the present invention, the thiosulfonization agent is introduced into the first oxidation reaction mixture at a reduced temperature of from about 5-10° C. and the reaction is continued at that reduced temperature before warming the reaction mixture to an elevated temperature of about 60° C., rather than warming the first reaction mixture to approximately 20-25°C. before introducing the thiosulfonization agent and then warming the resulting oxidization-thiosulfonization reaction mixture to the elevated temperature. After completing the thiosulfonization, the manufacturing process is continued in accordance the procedures disclosed in my prior International Application, i.e., the intermediate, 2-amino-5-dimethylaminophenyl thiosulfonic acid, is further oxidized and condensed with o-toluidine, in a second reaction mixture, forming a second intermediate, indamine thiosulfonic acid, the second intermediate is further oxidized in a third reaction mixture to close the indamine ring, forming a TBO reaction product, complexing the TBO reaction product in the third reaction mixture, forming a TBO-complex product, and separating the TBO-complex from the third reaction mixture.
- Thus, in accordance with my improved-yield process, the timing of addition of the thiosulfonization agent to the first reaction mixture is changed so that it is added before the temperature of the first reaction mixture is raised in later processing steps.
- Referring to FIG. 1, an aqueous solution of the starting
material 10 is oxidized 11, preferably at less than 10° C., especially at about 5°C., by reaction with a suitable oxidizingagent 12, e.g.,potassium dichromate 12, in the presence of acid, aluminum sulfate and a reagent, 13 (which is believed to complex the intermediate(s) and is used in a later stage of the process to complex the TBO composition components), e.g., zinc chloride. Then, before raising the temperature of the first reaction mixture, a source ofthiosulfate ions 14, e.g., sodium thiosulfate, is added and the reaction is continued at such reduced temperature for approximately 30 minutes and later at an elevated temperature of about 60° C., to form afirst reaction mixture 15 containing the first intermediate, 2-amino-5-dimethylaminophenyl thiosulfonic acid. - The
first reaction mixture 15 is then further reacted, preferably at a temperature of not greater than about 10°C., with additional oxidizingagent 16, e.g., potassium dichromate, and o-toluidine hydrochloride 17, in acondensation step 18 to form the second intermediate, a condensation product, indamine thiosulfonic acid in thesecond reaction mixture 19. - The
second reaction mixture 19 is then further oxidized 21, preferably by addition of a suitable oxidizingagent 22, e.g., potassium dichromate, at a temperature of not greater than about 10° C. This is followed by the addition of copper sulfate, zinc chloride complexing agent, acid and heating to 100° C. to effect closure of the indamine ring, forming TBO in athird reaction mixture 24. At this point the TBO is separated from the third reaction mixture and purified. - For example, in the presently preferred embodiment of the process of the present invention, the TBO is precipitated from the third reaction mixture by complexation of24 with a
suitable complexing agent 25, e.g., zinc chloride, to form the complex TBO-zinc chloride double salt. The precipitate is filtered 26 from the liquid phase and washed withsodium chloride solution 27. The washed filter cake is then redissolved 28 in a critical1 volume ofwater 29 to form aTBO solution 30, which is then filtered 31 to removeundissolved solids 32 a, which are discarded. Zinc Chloride, followed by a critical2 volume/concentration ofsodium chloride 33 is then added to thefiltrate 32 to again precipitate the TBO-zinc chloride double salt. Then, the TBO-zinc chloride double salt is separated from the mixture by filtration, to yield a TBO-zinc chloride/TBOhydrochloride filter cake 34. - As indicated by the
dashed line 35, theTBO filter cake 34 can be redissolved, filtered, re-precipitated and re-isolated multiple times to achieve the desired degree of purity and yield of TBO. The final purified filtercake complex product 34 is then dried 35, e.g., in conventional convection oven and/or vacuum oven and the driedfilter cake 36 is ground and blended 37 to yield thefinal TBO product 38. The final TBO product contains both the zinc chloride double-salt of TBO (Formula X) and the chloride salt of TBO (Formulas I & II). - The following example is presented to illustrate the practice of the invention in such terms as to enable those skilled in the art to make and use the novel TBO compositions, to practice the novel diagnostic methods using such TBO compositions and to practice the novel process for preparing TBO compositions, which together form the various embodiments of the invention, and to indicate to those skilled in the art the presently known best modes for practicing the various embodiments of the invention. These examples are presented as illustrative only and not as indicating limits on the scope of the invention, which is defined only by the appended claims.
- This example illustrates, in the detail required to satisfy regulatory required GMP conditions, the exact procedures for carrying out the commercial scale manufacture of a batch of TBO dye product, according to the process which embodies the presently known best mode of the invention.
- Equipment/supplies:
- A. Ohaus IP15KS Balance
- B. AnD HV150KAI Balance
- C. Fairbanks H90-5150 Balance
- D. OHAUS WB25/1-20W Balance
- E. Cole Parmer (51201-30) and Thermolyne (S25535)Stirrers
- F. Sampling devices, such as steel scoops, drum samplers, etc.
- G. Erlyenmeyer flasks, beakers, carboys and other appropriate glassware.
- H. Production Solution Labels.
- Safety:
- Protective equipment, such as gloves, safety glasses, lab coats, and respirators should be worn when handling chemicals according to MSDS guidelines.
- Raw Material Solutions Preparation Procedure:
- To Hydrochloric Acid, 1364.2 g (±5.5 g) add 1364.2 g (±5.5 g) of USP Purified water. Stir until the solution is clear.
- To Aluminum Sulfate Hexadecahydrate, 1779.1 g (±7.0 g) add 2548.9 g (±10.0 g) of USP Purified water. Stir until the solution is clear.
- To Zinc Chloride, 7384.6 g (±30.0 g), add 2786.7 g (±11.0 g) of USP Purified water. Stir until the solution is clear.
- To Potassium Dichromate, 2101.9 g (±8.0 g), add 25203.8 g (±100 g) of USP Purified water. Stir until the solution is clear.
- To Sodium Thiosulfate Pentahydrate, 1526.6 g (±6.0 g), add 2043.6 g (±8.0 g) of USP Purified water. Stir until the solution is clear.
- To Copper Sulfate Pentahydrate, 509.7 g (±2.0 g), add 1613.1 g (±6.0 g) of USP Purified water. Stir until the solution is clear.
- To Sulfuric Acid, 600.0 g (±2.0 g), add 600.0 g (±2.0 g) of USP Purified water. Stir until the solution is clear.
- To Sodium Chloride, 70.4 kg (±250 g), add 234.4 kg (±850 g) of USP Purified water. Stir until the solution is clear.
- Protective equipment, such as gloves, safety glasses, lab coats, and respirators should be worn when handling chemicals according to MSDS guidelines.
- Synthesis Equipment and Supplies:
- LFE Control Panel (3000)
- 20 gallon Jacketed Glass Lined Purification Tanks with lid (E71224)
- Two 100 gallon Jacketed Glass Lined Purification Tank with lids (P1, PT-001)(P2, L-13621)
- FTS Recirculating Cooler (RC96C032) and 500 gallon Cold Storage Tank (500CST)
- Three Caframo Mixers (BDC-1850) (R1, 18500961)(P1, 18501148) (P2, 18501173) with shaft and impeller
- Lightning Mixer (L1U08) (201550)
- Three Heat Exchangers (Gardner Machinery) (R1, 01960763) (P1, 01960764) (P2, 08950727)
- Three 12KW Jacket Fluid recirculators (Watlow, BLC726C3S 20)
- Three Recirculation Pumps (Sta-Rite, JBHD-62S, C48J2EC15)
- Masterflex Digital Peristaltic Pump (A94002806)
- Masterflex Peristaltic Pump (L95003320)
- Cole Parmer Peristaltic Pump (B96002074)
- Neutsche Filtration unit (70-2038, 43421-1)
- Two Buchner Filtration Units (Z11,624-6, Z10,441-8)
- Siemens Vacuum Pump (F2BV2)
- 60 Gallon Glass Lined Collection Tank with lid (86854, E164-1186)
- Air Compressor (DF412-2) (9502312538)
- Flow Controller (3-5500) (69705069190)
- Six Batch Controllers (3-5600) (#1,69705069191, #2, 69705069199, #3, 69705069194, #4, 69705058829, #5, 69705058805, #6, 69705069195)
- Six Flow Sensors (#1, 69704295165, #2, 69704024995, #3, 69704024994, #4, 69704025027, #5, 69612178606, #6, 69703120990)
- Four Diaphragm Pumps (M1)
- Four Surge Suppressers (A301H) (#2, 15557, #3, 15561, #4, 15558, #5, 15559)
- Four Air Regulators (CFR10)
- Four Solenoid Valves (used with air regulators)
- Four Low Flow Sensors (FS-500)
- Three Solenoid Valves (EASM5V16W20)
- Air Filter/Regulator (T1R)PTFE/F06R113AC
- Filter media, Polypropylene (7211-1)
- Filter media, Whatman Grade 52
- PharMed tubing (-18, -82, -90)
- pH Meter; Hanna 9321 (1303675) & Orion 620 (001911)
- Spectrophotometer 20 (3MU7202070)
- Fisher Scientific Vacuum Oven (9502-033)
- VWR 1370 FM forced air oven (1370FM)
- Dust/Mist Respirator
- Thomas Wiley Laboratory Mill (3375-E10)
- Patterson-Kelley Blender (Blendmaster, C416578)
- OHAUS TS4KD Balance
- OHAUS IP15KS Balance
- Mettler AG 104 Balance
- AnD HV150KA1 Balance
- Fairbanks H90-5150 Balance
- OHAUS AS123 Printer
- OHAUS AS142 Printer
- AD-8121 Multifunction Printer
- Citizen iDP 3540 Dot Matrix Printer
- Hewlett Packard HPLC (1050)
- Ultrasonic Cleaner (8892-DTH, QCC9601 005C)
- Type K Thermocouple Temperature Recorder (KTx, 6292753, 6355146)
- Erlenmeyer Flasks (8 L, 6 L, 4 L, 1 L)
- Beakers (8 L, 6 L, 500 mL, 250 mL)
- Carboys (4 L, 10 L, 50 L)
- HDPE Drums (55 gallon, 100 gallon)
- Volumetric Flasks (100 mL)
- Plastic Funnel
- Pastuer Pipettes & Bulbs and Volumetric Pipettes (10 mL, 5 mL) & Bulb
- Bellows (25 mL, 50 mL)
- Weigh Paper
- Spatulas
- Packaging Material (containers, lids, labels)
- Raw Material Solutions
- Check the integrity of the USP water system. To the reactor add the weighed USP Grade Purified Water (28,000 g±100.0 g) and stir at 190±10 RPM. Record the conductivity of the USP water at the time the water was dispensed.
- Add N,N-dimethyl-1,4-phenylenediamine (5.128 mol. 720.0 g±3.0 g). The material should be added as a powder (no lumps).
Stir 10 minutes (±5 minutes). - Add hydrochloric acid (6 N, 1136.9 g±5.0 g).
Stir 15 minutes (±5 minutes). - Ensure the pH meter is calibrated according to SOP # LM-007. Take a reaction mixture sample of approximately 10 mL using a plastic sampling device. Mark the sample lot #.IPS1a. Check the pH and record. The pH must be 2.8 - 3.8 @ 25° C.±5° C.
- Add aluminum sulfate hexadecahydrate solution (4328.0 g±21.0 g).
Stir 10 minutes (±5 minutes) at 275±10 RPM. - Add zinc chloride solution (3641.5 g±18.0 g). Cool to 4°C.±1°C.
- Once the temperature (PV1) is 4°C.±1°C. add potassium dichromate solution (6532.4 g±32.0 g) over a 20 minute period (±5 minutes). When addition is complete stir 20 minutes (±5 minutes) and then change the Set Point (SP1) to 25.0° C. from the Main Menu.
- While maintaining the temperature at less than 10°C., add sodium thiosulfate pentahydrate solution (3570.2 g±18.0 g). Stir the solution at ≈5° C. for 30 minutes (±5 minutes).
- Change the Set Point to 25° C. When the temperature (PV1) reaches 25° C.±5° C., stir for 20 minutes. Change the Set Point on the LFE controller to 10.0.
- Once the temperature has reached 13.0° C.±2.0° C. take a reaction mixture sample of approximately 10 mL using a plastic sampling device. Mark the sample lot #.IPS1b. Check the pH and record. The pH must be 3.1-4.1 @ 25° C.±5° C.
- Weigh out o-toluidine (604.4 g±2.5 g) and cool to 18° C.±3°C. in an ice bath. Add hydrochloric acid (6 N, 1230.7 g±5.0 g) to the o-toluidine slowly. Remove the o-toluidine hydrochloride from the ice bath and allow the solution to cool to 38° C.±3° C. Add the solution to the reaction mixture and stir 5 minutes (±3 minutes).
- Add potassium dichromate solution (6532.4 g±32.0 g) over a 20 minute period (±5 minutes). When addition is
complete stir 10 minutes (±5 minutes). - Change the controller Set Point (SP1) to 60.0. Once the reaction mixture temperature reaches 60.0°C.±3° C. allow the mixture to stir 25 minutes (±5 minutes). A precipitate will form consisting of a green indamine.
- Take a reaction mixture sample of approximately 10 mL using a pipette. Mark the sample lot #.IPS2. Record the solution color.
- Set the LFE controller Set Point to 7.0. Once the reaction mixture temperature reaches 10.0° C.±3° C. add potassium dichromate solution (6532.4 g±32.0 g) over a 20 minute period (±5 minutes). When addition is complete stir 20 minutes.
- Add potassium dichromate solution (5225.9 g±26.0 g) over a 20 minute period (±5 minutes). When addition is complete stir 20 minutes (±5 minutes).
- Take a reaction mixture sample of approximately 10 mL using a pipette. Mark the sample lot #.IPS3.
- Add zinc chloride solution (3641.5 g±18.0 g). Stir 20 minutes (±5 minutes) at 350±10 RPM.
- Add copper sulfate pentahydrate (2122.8 g±10.0 g).
Stir 15 minutes (±5 minutes). - Take a reaction mixture sample of approximately 10 mL using a pipette. Mark the sample lot #.IPS4.
- Change the controller Set Point (SP1) to 100.0. Once the reaction mixture temperature reaches 67.0° C.±3° C. begin to add sulfuric acid solution to pH 2.9±0.3 by adding aliquots (500 mL, 250, 125 mL, etc.). Stir for 5 to 10 minutes after each addition and check pH.
- Once the reaction mixture temperature reaches 100.0° C.±3° C. allow the mixture to stir 35±5 minutes.
- Change the controller Set Point (SP1) to 35.0. Once the reaction mixture temperature reaches 70.0° C.±3° C. take a reaction mixture sample of approximately 10 mL using a pipette. Mark the sample lot #.IPS5.
- Change the controller Set Point (SP1) to 2.5. Cool to 2.5° C. in 4 hours and Hold at 2.5° C.±2.0° C. for 4 to 18 hours.
- Take a reaction mixture sample of approximately 10 mL using a pipette. Mark the sample lot #.IPS6. Record the solution color. Check the pH and record. Filter the sample through 0.45 micron filter paper. Take approximately 100 milligrams of the precipitate and dissolve in approximately 100 mL of HPLC water. Filter the solution through 0.45 micron filter paper. Label the solution Lot # .IPS7 and analyze the sample by the RP-HPLC Toluidine Blue O Analysis Method. See Example 3. Record the results.
- Filter the reaction mixture through suitable filter media (Whatman Grade 52).
- When the reactor is empty weigh out 24.0 kg±150.0 g of 30% NaCl solution and add 24.0 kg±150.0 g of USP water (record conductivity of the dispensed water). Close the reactor bottom valve and add the 15% NaCl solution to the reactor. Stir the solution briefly. When the filtration is complete add the NaCl solution to the filtration unit to rinse the filter cake. Collect the filtrate into the same container and Label lot#.HW1 (hazardous waste1).
- Process filtrate (lot#. HW1) according to waste disposal procedures.
- Check the 100 gallon glass lined, jacketed purification tank #1 condition and make certain the tank has been properly labeled as CLEANED with date and signature. Equip the tank with a HDPE lid, Caframo stirrer, stir shaft, propeller and thermocouple probe inserted into a plastic thermocouple well. Check that the bottom valve is off and the outlet is capped.
- Label the Tank with Lot#.P1A (Purification 1A).
- Weigh out 190.0 kg±1.0 kg of USP water into a HDPE container (record conductivity of the dispensed water) and transfer the water to Purification Tank1. Stir the mixture at 350 RPM. Once the NaCl wash of the filter cake is complete add the filter cake to Purification Tank 1 while stirring.
- Stir the mixture 2 to 4 hours. Take a sample (through the bottom valve) of approximately 50 mL. Mark the sample lot#.IPS8. Record the solution color.
- Set the Purification Tank1 LFE controller to 75.0 (SP1).
- When the mixture temperature (PV1) reaches 75.0° C.±3°C. change the Set Point on the controller to 40.0.
- Allow the mixture to stir at40° C. and 350 RPM for 12 to 36 hours.
- Take a sample (through the bottom valve) of approximately 50 mL. Mark the sample lot#.IPS9. Record the solution color. Check the pH and record. Measure 1.0 mL of the sample with a 1.0 mL pipette and dilute to 100 mL in a volumetric 100 mL flask. Label the sample lot#.IPS9A. Then take 10.0 mL of this solution with a 10.0 mL pipette and dilute to 100 mL in a volumetric 100 mL flask. Label the sample lot#.IPS9B. Measure the absorbance of these samples using the spectronic 20+. Record the results. The absorbance of sample9B should be >0.220.
- Filter the mixture through filter media in the filtration unit. Collect the filtrate into a Tared HDPE container with lid.
- Check the 100 gallon glass lined, jacketed purification tank #2 condition and make certain the tank has been properly labeled as CLEANED with date and signature. Equip the tank with a HDPE lid, Caframo stirrer, stir shaft, propeller and thermocouple probe inserted into a plastic thermocouple well. Check that the bottom valve is labeled as CLEANED, off (horizontal position) and the outlet is capped.
- Label the Tank with Lot#.P2A (Purification 2A), date and signature.
- When the filtration is complete weigh the container and solution. Subtract the tare weight. Record the solution weight. Calculate the solution volume.
- (TBO soln wt. g)(100.0 mL TBO soln/100.42 g TBO soln)=ml of TBO soln
- Label the filter cake lot#.HW2 (Hazardous Waste2) and process according to waste disposal procedures.
- Into a clean HDPE container weigh out a quantity of 30% NaCl solution equal to the solution volume recorded above using the following formula:
- (mL of TBO soln)(116.91 g NaCl soln/100.0 mL NaCl soln)=g of NaCl soln
- Sample ≈10 mL of the filtrate and check the pH. Label lot#.IPS10. The pH must be 3.0 - 4.0. Transfer the filtrate (by weight) to Purification Tank2. Stir the solution at 350 RPM.
- Add zinc chloride solution (1636.3 g±6.5 g)
- Transfer the NaCl solution (by weight) to Purification Tank2.
- Set the Purification Tank2 LFE controller to 75.0 (SP1).
- When the mixture temperature (PV1) reaches 75.0° C.±3° C. change the Set Point on the controller to 5.0.
- Cool to 5° C. in 6 hours and Hold at 5° C.±4.0° C. for 4 to 24 hours.
- Take a sample (through the bottom valve) of approximately 50 mL. Mark the sample lot#.IPS11.PT2..
- i. Filter
- Filter the mixture through tared filtration media (Whatman Grade 52) in the filtration unit
- Weigh out 12 kg±50 g of 30% sodium chloride solution and dilute with 12 kg±50 g of USP water (record conductivity of the dispensed water). Wash the filter cake with the 15% sodium chloride solution by adding the solution directly to the buchner. When the filtration is complete carefully remove the filter paper containing the toluidine blue O product.
- Process Lot#.HW3 (Hazardous Waste3) according to waste disposal procedures.
- ii. Dry
- Place the TBO product in the oven and dry at 50.0° C.±3.0° C. for 5±1 hours. Label the oven lot#.PRE-DRY.
-
- iii. Weigh
- Remove the product and weigh the Toluidine Blue O and filter. Subtract the filter weight and record the TBO weight.
- Using a stainless steel spatula carefully remove the product from the filter paper. Wear a Dust/Mist respirator. Weigh the Toluidine Blue.
- iv. Grind
- Transfer the product to the TOLUIDINE BLUE O FINISHING AREA. Check the Thomas Wiley Laboratory Mill condition and make certain the mill has been properly labeled as CLEANED with date and signature. Use the 0.5 mm screen. Attach a clean container to the delivery chute. The chamber door must be closed and latched.
- Close the sliding shutter at the bottom of the hopper, remove the hopper lid and add the sample. Replace the hopper lid. Turn the mill ON and open the sliding shutter slightly. Feed sample into the mill chamber slowly enough so that the mill does not slow down or become jammed.
- Once the grinding is complete carefully remove the mason jar from the delivery chute.
- v. Blend
- Check the Patterson-Kelly Lab Blender condition and make certain the blender has been properly labeled as CLEANED with date and signature.
- Transfer the Toluidine Blue O product to the blender container and close the lid. Set the timer to 15 minutes±5 min.
- vi. Test
- Sample the product for testing. Analyze the sample by the RP-HPLC Toluidine Blue O Analysis Method. Record the results.
- Having described my invention in such terms as to enable persons skilled in the art to understand the invention and practice it, and, having identified the presently preferred embodiments thereof,
Claims (2)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/759,808 US6372904B2 (en) | 1997-11-13 | 2001-01-11 | Process for manufacture of in vivo stain composition |
US10/096,468 US20020111501A1 (en) | 1997-11-13 | 2002-03-11 | Process for manufacture of in vivo stain composition |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1997/020981 WO1999025388A1 (en) | 1997-11-13 | 1997-11-13 | In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue |
US09/110,788 US6194573B1 (en) | 1997-11-13 | 1998-07-06 | Process for manufacture of in vivo stain composition |
US09/759,808 US6372904B2 (en) | 1997-11-13 | 2001-01-11 | Process for manufacture of in vivo stain composition |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/110,788 Continuation US6194573B1 (en) | 1997-11-13 | 1998-07-06 | Process for manufacture of in vivo stain composition |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/096,468 Continuation US20020111501A1 (en) | 1997-11-13 | 2002-03-11 | Process for manufacture of in vivo stain composition |
Publications (2)
Publication Number | Publication Date |
---|---|
US20010007904A1 true US20010007904A1 (en) | 2001-07-12 |
US6372904B2 US6372904B2 (en) | 2002-04-16 |
Family
ID=22334939
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/110,788 Expired - Lifetime US6194573B1 (en) | 1997-11-13 | 1998-07-06 | Process for manufacture of in vivo stain composition |
US09/759,808 Expired - Lifetime US6372904B2 (en) | 1997-11-13 | 2001-01-11 | Process for manufacture of in vivo stain composition |
US10/096,468 Abandoned US20020111501A1 (en) | 1997-11-13 | 2002-03-11 | Process for manufacture of in vivo stain composition |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/110,788 Expired - Lifetime US6194573B1 (en) | 1997-11-13 | 1998-07-06 | Process for manufacture of in vivo stain composition |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/096,468 Abandoned US20020111501A1 (en) | 1997-11-13 | 2002-03-11 | Process for manufacture of in vivo stain composition |
Country Status (10)
Country | Link |
---|---|
US (3) | US6194573B1 (en) |
EP (1) | EP0966957A3 (en) |
JP (1) | JPH11209357A (en) |
CN (1) | CN1188173C (en) |
CZ (1) | CZ299736B6 (en) |
HU (1) | HUP9802577A3 (en) |
IL (1) | IL125602A (en) |
PL (2) | PL192629B1 (en) |
SG (1) | SG67571A1 (en) |
SK (1) | SK285184B6 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194573B1 (en) * | 1997-11-13 | 2001-02-27 | Zila, Inc. | Process for manufacture of in vivo stain composition |
IL145589A0 (en) * | 2000-01-31 | 2002-06-30 | Zila Inc | In vivo stain compounds and methods of use to identify dysplastic tissue |
JP2004504615A (en) * | 2000-07-20 | 2004-02-12 | ジラ・インク | Improved diagnostic method for detecting dysplastic epithelial tissue |
AU776256B2 (en) * | 2000-09-26 | 2004-09-02 | Zila Biotechnology, Inc. | Method for early prediction of the onset of invasive cancer |
US20040146919A1 (en) * | 2002-05-18 | 2004-07-29 | Burkett Douglas D. | Method for early prediction of the onset of invasive cancer |
US7462346B2 (en) * | 2001-08-28 | 2008-12-09 | Zila Biotechnology, Inc. | Light-stabilized(in vivo) stain composition and method of manufacture |
JP3693324B2 (en) * | 2001-10-30 | 2005-09-07 | ダイセル化学工業株式会社 | Sample moving device for simulated moving bed chromatography |
US20030120180A1 (en) * | 2001-12-21 | 2003-06-26 | Kimberly-Clark Worldwide, Inc. | Method and apparatus for collecting and testing biological samples |
US20060110326A1 (en) * | 2002-06-04 | 2006-05-25 | Zila, Inc. | Toluidine blue o drug substance and use thereof for in vitro staining and chemotherapeutic treatment of dysplastic tissues |
EP1534346A4 (en) * | 2002-06-04 | 2007-07-25 | Zila Inc | Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
US20090023138A1 (en) * | 2007-07-17 | 2009-01-22 | Zila Biotechnology, Inc. | Oral cancer markers and their detection |
CN102958525B (en) | 2010-04-30 | 2017-05-24 | 普罗瑟塔抗病毒股份有限公司 | Antiviral compounds |
CN102221526A (en) * | 2011-03-09 | 2011-10-19 | 叶欣 | Composite reagent for screening early-stage oral intima cell disease and application method thereof |
EP2699241B1 (en) | 2011-04-20 | 2016-07-27 | Prosetta Antiviral Inc. | Antiviral compounds |
GB201621817D0 (en) | 2016-12-21 | 2017-02-01 | Wista Lab Ltd | Methods of chemical synthesis |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US416055A (en) | 1889-11-26 | On - the - rhine | ||
US4237281A (en) * | 1978-10-13 | 1980-12-02 | Ciba-Geigy Aktiengesellschaft | Dyestuffs containing amino or imino groups |
US4212971A (en) * | 1979-03-08 | 1980-07-15 | American Cyanamid Company | Process for preparing methylene blue |
US4859667A (en) * | 1983-01-21 | 1989-08-22 | Merck Frosst Canada, Inc. | Pharmaceutical compositions of phenothiazone derivatives and analogs |
US4622395A (en) * | 1984-10-01 | 1986-11-11 | Minnesota Mining And Manufacturing Company | Phenoxazine and phenothiazine dyes and leuco forms thereof |
US5344928A (en) * | 1991-04-26 | 1994-09-06 | Takeda Chemical Industries, Ltd. | Phenothiazine derivatives, their production and use |
EP0565668B1 (en) * | 1991-10-31 | 1999-06-23 | Zila Inc. | Biological stain composition, method of preparation and method of use for delineation of epitheleal cancer |
US5631371A (en) * | 1995-11-22 | 1997-05-20 | Bayer Corporation | Method for the preparation of substituted 3-(phenylimino)-3H-phenothiazines and phenoxazines |
JPH10511702A (en) * | 1996-01-16 | 1998-11-10 | ジラ・ファーマスーティカルス・インコーポレーテッド | Methods and compositions for the detection of oral cancer and precancerous symptoms in vivo |
US6194573B1 (en) * | 1997-11-13 | 2001-02-27 | Zila, Inc. | Process for manufacture of in vivo stain composition |
-
1998
- 1998-07-06 US US09/110,788 patent/US6194573B1/en not_active Expired - Lifetime
- 1998-07-30 IL IL125602A patent/IL125602A/en not_active IP Right Cessation
- 1998-10-12 SG SG1998004175A patent/SG67571A1/en unknown
- 1998-10-16 JP JP10295607A patent/JPH11209357A/en active Pending
- 1998-10-28 EP EP98308824A patent/EP0966957A3/en not_active Withdrawn
- 1998-11-04 CZ CZ0355598A patent/CZ299736B6/en not_active IP Right Cessation
- 1998-11-04 SK SK1512-98A patent/SK285184B6/en unknown
- 1998-11-06 HU HU9802577A patent/HUP9802577A3/en not_active Application Discontinuation
- 1998-11-10 CN CNB981241425A patent/CN1188173C/en not_active Expired - Fee Related
- 1998-11-10 PL PL329658A patent/PL192629B1/en not_active IP Right Cessation
- 1998-11-10 PL PL377397A patent/PL193407B1/en not_active IP Right Cessation
-
2001
- 2001-01-11 US US09/759,808 patent/US6372904B2/en not_active Expired - Lifetime
-
2002
- 2002-03-11 US US10/096,468 patent/US20020111501A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0966957A2 (en) | 1999-12-29 |
PL192629B1 (en) | 2006-11-30 |
PL329658A1 (en) | 1999-05-24 |
PL193407B1 (en) | 2007-02-28 |
CZ355598A3 (en) | 1999-06-16 |
EP0966957A3 (en) | 2000-12-06 |
US6194573B1 (en) | 2001-02-27 |
US20020111501A1 (en) | 2002-08-15 |
CN1188173C (en) | 2005-02-09 |
CN1225278A (en) | 1999-08-11 |
HUP9802577A2 (en) | 1999-07-28 |
SK151298A3 (en) | 2000-07-11 |
IL125602A (en) | 2007-09-20 |
IL125602A0 (en) | 1999-03-12 |
SG67571A1 (en) | 1999-09-21 |
US6372904B2 (en) | 2002-04-16 |
JPH11209357A (en) | 1999-08-03 |
HUP9802577A3 (en) | 2000-04-28 |
CZ299736B6 (en) | 2008-11-05 |
SK285184B6 (en) | 2006-08-03 |
HU9802577D0 (en) | 1999-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6194573B1 (en) | Process for manufacture of in vivo stain composition | |
US6086852A (en) | In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue | |
TW527185B (en) | In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue | |
CN101622198A (en) | The method for preparing titanium dioxide | |
CN209302715U (en) | A kind of Norfloxacin production reactant Dropping feeder | |
CN108864271A (en) | A kind of preparation method of iron protein succinylate | |
CA2250731C (en) | In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue | |
AU757963B2 (en) | In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue | |
CN103159786B (en) | Preparation method for high-purity sterilized cefmenoxime hydrochloride and pharmaceutical composition containing cefmenoxime hydrochloride | |
KR100641972B1 (en) | Methods used to identify dye compounds and dysplastic tissues in vivo | |
MXPA98009501A (en) | Compositions for in vivo staining, manufacturing process and methods of use to identify displasi tissues | |
CN109364830A (en) | A kind of reactant dropping device for norfloxacin production | |
ZA200107818B (en) | In-vivo Stain compounds and methods of use to identify dysplastic tissue. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ZILA, INC., ARIZONA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BURKETT, DOUGLAS D.;REEL/FRAME:011693/0461 Effective date: 20010306 |
|
AS | Assignment |
Owner name: CONGRESS FINANCIAL CORPORATION (WESTERN), CALIFORN Free format text: SECURITY INTEREST;ASSIGNOR:ZILA, INC.;REEL/FRAME:012134/0895 Effective date: 20010817 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: ZILA BIOTECHNOLGY, INC., ARIZONA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ZILA, INC.;REEL/FRAME:014066/0881 Effective date: 20030425 Owner name: ZILA BIOTECHNOLGY, INC.,ARIZONA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ZILA, INC.;REEL/FRAME:014066/0881 Effective date: 20030425 |
|
AS | Assignment |
Owner name: WELLS FARGO BUSINESS CREDIT, INC., ARIZONA Free format text: SECURITY AGREEMENT;ASSIGNORS:ZILA NUTRACEUTICALS, INC;ZILA BIOTECHNOLOGY, INC.;ZILA PHARMACEUTICALS, INC.;AND OTHERS;REEL/FRAME:015687/0374 Effective date: 20040206 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: BLACK DIAMOND COMMERCIAL FINANCE, L.L.C.,CONNECTIC Free format text: SECURITY AGREEMENT;ASSIGNORS:ZILA, INC.;ZILA BIOTECHNOLOGY, INC.;ZILA NUTRACEUTICALS, INC.;AND OTHERS;REEL/FRAME:017411/0081 Effective date: 20060324 Owner name: BLACK DIAMOND COMMERCIAL FINANCE, L.L.C., CONNECTI Free format text: SECURITY AGREEMENT;ASSIGNORS:ZILA, INC.;ZILA BIOTECHNOLOGY, INC.;ZILA NUTRACEUTICALS, INC.;AND OTHERS;REEL/FRAME:017411/0081 Effective date: 20060324 |
|
AS | Assignment |
Owner name: ZILA, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CONGRESS FINANCIAL CORPORATION (WESTERN);REEL/FRAME:017931/0198 Effective date: 20060713 |
|
AS | Assignment |
Owner name: ZILA, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WELLS FARGO BANK, NATIONAL ASSOCIATION;REEL/FRAME:017982/0579 Effective date: 20060717 Owner name: ZILA TECHNICAL, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WELLS FARGO BANK, NATIONAL ASSOCIATION;REEL/FRAME:017982/0579 Effective date: 20060717 Owner name: ZILA BIOTECHNOLOGY, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WELLS FARGO BANK, NATIONAL ASSOCIATION;REEL/FRAME:017982/0579 Effective date: 20060717 Owner name: ZILA NUTRACEUTICALS, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WELLS FARGO BANK, NATIONAL ASSOCIATION;REEL/FRAME:017982/0579 Effective date: 20060717 Owner name: ZILA PHARMACEUTICALS, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WELLS FARGO BANK, NATIONAL ASSOCIATION;REEL/FRAME:017982/0579 Effective date: 20060717 Owner name: ZILA SWAB TECHNOLOGIES, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WELLS FARGO BANK, NATIONAL ASSOCIATION;REEL/FRAME:017982/0579 Effective date: 20060717 |
|
AS | Assignment |
Owner name: ZILA, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BLACK DIAMOND COMMERCIAL FINANCE, L.L.C.;REEL/FRAME:018323/0754 Effective date: 20061002 Owner name: ZILA, INC.,ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BLACK DIAMOND COMMERCIAL FINANCE, L.L.C.;REEL/FRAME:018323/0754 Effective date: 20061002 Owner name: ZILA BIOTECHNOLOGY, INC.,ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BLACK DIAMOND COMMERCIAL FINANCE, L.L.C.;REEL/FRAME:018323/0754 Effective date: 20061002 Owner name: ZILA TECHNICAL, INC.,ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BLACK DIAMOND COMMERCIAL FINANCE, L.L.C.;REEL/FRAME:018323/0754 Effective date: 20061002 Owner name: ZILA NUTRACEUTICALS, INC.,ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BLACK DIAMOND COMMERCIAL FINANCE, L.L.C.;REEL/FRAME:018323/0754 Effective date: 20061002 Owner name: ZILA SWAB TECHNOLOGIES, INC.,ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BLACK DIAMOND COMMERCIAL FINANCE, L.L.C.;REEL/FRAME:018323/0754 Effective date: 20061002 Owner name: ZILA BIOTECHNOLOGY, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BLACK DIAMOND COMMERCIAL FINANCE, L.L.C.;REEL/FRAME:018323/0754 Effective date: 20061002 Owner name: ZILA SWAB TECHNOLOGIES, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BLACK DIAMOND COMMERCIAL FINANCE, L.L.C.;REEL/FRAME:018323/0754 Effective date: 20061002 Owner name: ZILA TECHNICAL, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BLACK DIAMOND COMMERCIAL FINANCE, L.L.C.;REEL/FRAME:018323/0754 Effective date: 20061002 Owner name: ZILA NUTRACEUTICALS, INC., ARIZONA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BLACK DIAMOND COMMERCIAL FINANCE, L.L.C.;REEL/FRAME:018323/0754 Effective date: 20061002 |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
SULP | Surcharge for late payment |
Year of fee payment: 7 |
|
AS | Assignment |
Owner name: ZILA, INC.,COLORADO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ZILA BIOTECHNOLOGY, INC.;REEL/FRAME:024170/0750 Effective date: 20100324 |
|
FPAY | Fee payment |
Year of fee payment: 12 |
|
AS | Assignment |
Owner name: DEN-MAT HOLDINGS, LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ZILA, INC.;REEL/FRAME:032256/0187 Effective date: 20140214 |
|
AS | Assignment |
Owner name: MIDCAP FUNDING V, LLC, AS ADMINISTRATIVE AGENT, MA Free format text: SECOND AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNORS:DEN-MAT HOLDINGS, LLC;PERIOPTIX, INC.;REEL/FRAME:032382/0567 Effective date: 20140214 |